← Leaderboards

Benjamin Levine Ebert

Dana-Farber Cancer Inst

Google Scholar ↗PubMed ↗ORCID ↗

$26,802,844

Attributed

$34,500,214

Total exposure

26

Grants

24

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $16.2M · FY2005–25

$20M$15M$10M$5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$94,115,957 · 29

By mechanism

P01$27,786,594 · 8

P30$26,100,648 · 2

P50$18,795,290 · 9

R24$8,774,776 · 2

R01$5,886,992 · 2

R35$4,930,868 · 1

Top collaborators

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Nathanael Schiander Gray$36,761,550

Others in their field

Top investigators on “Molecular”

David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
Richard Webby · St. Jude Children'S Research Hospital$254,843,170
Larry Arthur$238,531,074
Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914

Research focus

MolecularLeukemiaGeneticBaseResearch PersonnelFundingProgramsNovel TherapeuticsLaboratoriesCellsMalignant NeoplasmsGenesMemberDysmyelopoietic SyndromesSamplingClinical TrialsBiologicalMyeloproliferative DiseaseCollaborationsClinical ResearchBiologyLeadHematopoiesisIn Vivo

Grant awards (105)

Dana-Farber/Harvard Cancer Center$12,713,161

P30 · FY2025 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$2,052,164

P01 · FY2025 · CA · contact PI

Molecular basis for microtubule-destabilization dependent MYB degradation$389,348

P01 · FY2025 · CA · contact PI

Dana-Farber/Harvard Cancer Center$208,750

P30 · FY2025 · CA · contact PI

Administrative Core$111,026

P01 · FY2025 · CA · contact PI

NCI Early Career Cancer Clinical Investigator Award$31,074

P30 · FY2025 · CA · contact PI

Dana-Farber/Harvard Cancer Center$12,713,161

P30 · FY2024 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$1,868,170

P01 · FY2024 · CA · contact PI

The role of clonal hematopoiesis in the development and therapy of myeloid malignancies$954,038

R35 · FY2024 · CA · contact PI

Targeted aberrant signaling in CBL-mutant leukemia$374,064

P01 · FY2024 · CA · contact PI

Dana-Farber/Harvard Cancer Center$208,750

P30 · FY2024 · CA · contact PI

Administrative Core$58,463

P01 · FY2024 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$1,966,495

P01 · FY2023 · CA · contact PI

The role of clonal hematopoiesis in the development and therapy of myeloid malignancies$984,165

R35 · FY2023 · CA · contact PI

Targeted aberrant signaling in CBL-mutant leukemia$385,968

P01 · FY2023 · CA · contact PI

Administrative Core$76,678

P01 · FY2023 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$1,927,163

P01 · FY2022 · CA · contact PI

The role of clonal hematopoiesis in the development and therapy of myeloid malignancies$984,165

R35 · FY2022 · CA · contact PI

Functional Genomic Dissection of Refractory Anemia$441,250

R01 · FY2022 · HL · contact PI

Targeted aberrant signaling in CBL-mutant leukemia$380,349

P01 · FY2022 · CA · contact PI

Administrative Core$71,059

P01 · FY2022 · CA · contact PI

SPORE in Myeloid Malignancies$2,138,999

P50 · FY2021 · CA · contact PI

Administrative Core A$1,995,151

P50 · FY2021 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$1,966,495

P01 · FY2021 · CA · contact PI

The role of clonal hematopoiesis in the development and therapy of myeloid malignancies$1,004,250

R35 · FY2021 · CA · contact PI

Functional Genomic Dissection of Refractory Anemia$441,250

R01 · FY2021 · HL · contact PI

Targeted aberrant signaling in CBL-mutant leukemia$388,111

P01 · FY2021 · CA · contact PI

Administrative Core$72,510

P01 · FY2021 · CA · contact PI

Targeting SF3B1 for the treatment of MDS$20,549

P50 · FY2021 · CA · contact PI

Administrative Core A$2,069,128

P50 · FY2020 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$2,012,011

P01 · FY2020 · CA · contact PI

SPORE in Myeloid Malignancies$1,881,692

P50 · FY2020 · CA · contact PI

The role of clonal hematopoiesis in the development and therapy of myeloid malignancies$1,004,250

R35 · FY2020 · CA · contact PI

Functional Genomic Dissection of Refractory Anemia$441,250

R01 · FY2020 · HL · contact PI

Targeted aberrant signaling in CBL-mutant leukemia$394,614

P01 · FY2020 · CA · contact PI

Developmental Research Program$138,001

P50 · FY2020 · CA · contact PI

Administrative Core$79,013

P01 · FY2020 · CA · contact PI

Administrative Core A$2,138,999

P50 · FY2019 · CA · contact PI

SPORE in Myeloid Malignancies$2,138,999

P50 · FY2019 · CA · contact PI

Functional Genomic Dissection of Refractory Anemia$441,250

R01 · FY2019 · HL · contact PI

Program 4: Leukemia$73,081

P30 · FY2019 · CA · contact PI

Program 4: Leukemia$6,168

P30 · FY2019 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$2,247,411

P01 · FY2018 · CA · contact PI

SPORE in Myeloid Malignancies$1,440,214

P50 · FY2018 · CA · contact PI

SPORE in Myeloid Malignancies$859,786

P50 · FY2018 · CA · contact PI

Functional Genomic Dissection of Refractory Anemia$443,750

R01 · FY2018 · HL · contact PI

Targeting SF3B1 for the treatment of MDS$364,030

P50 · FY2018 · CA · contact PI

Determination of the mechanism of lenalidomide activity in acute myeloid leukemia$327,858

P01 · FY2018 · CA · contact PI

Project-005$222,500

P50 · FY2018 · CA · contact PI

Administrative Core A$181,152

P50 · FY2018 · CA · contact PI

Developmental Research Program$159,497

P50 · FY2018 · CA · contact PI

Project-007$126,009

P50 · FY2018 · CA · contact PI

Program 4: Leukemia$74,743

P30 · FY2018 · CA · contact PI

Core-004$67,906

P50 · FY2018 · CA · contact PI

Administrative Core$53,862

P01 · FY2018 · CA · contact PI

Admin-Core-002$33,422

P50 · FY2018 · CA · contact PI

Project-006$17,983

P50 · FY2018 · CA · contact PI

Program 4: Leukemia$11,431

P30 · FY2018 · CA · contact PI

Program 4: Leukemia$5,849

P30 · FY2018 · CA · contact PI

Program 4: Leukemia$5,123

P30 · FY2018 · CA · contact PI

Program 4: Leukemia$3,833

P30 · FY2018 · CA · contact PI

Program 4: Leukemia$1,602

P30 · FY2018 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$2,248,452

P01 · FY2017 · CA · contact PI

SPORE in Myeloid Malignancies$2,185,000

P50 · FY2017 · CA · contact PI

Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,636,056

R24 · FY2017 · DK

Functional Genomic Dissection of Refractory Anemia$443,750

R01 · FY2017 · HL · contact PI

Targeting SF3B1 for the treatment of MDS$349,029

P50 · FY2017 · CA · contact PI

Determination of the mechanism of lenalidomide activity in acute myeloid leukemia$327,867

P01 · FY2017 · CA · contact PI

Administrative Core A$184,925

P50 · FY2017 · CA · contact PI

Developmental Research Program$82,319

P50 · FY2017 · CA · contact PI

Administrative Core$53,864

P01 · FY2017 · CA · contact PI

Program 4: Leukemia$43,922

P30 · FY2017 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$2,249,567

P01 · FY2016 · CA · contact PI

Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,636,073

R24 · FY2016 · DK

Functional Genomic Dissection of Refractory Anemia$443,750

R01 · FY2016 · HL · contact PI

Determination of the mechanism of lenalidomide activity in acute myeloid leukemia$327,877

P01 · FY2016 · CA · contact PI

Administrative Core$53,864

P01 · FY2016 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$2,250,582

P01 · FY2015 · CA · contact PI

Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,635,660

R24 · FY2015 · DK

Functional Genomic Dissection of Refractory Anemia$443,542

R01 · FY2015 · HL · contact PI

Determination of the mechanism of lenalidomide activity in acute myeloid leukemia$327,887

P01 · FY2015 · CA · contact PI

Administrative Core$53,863

P01 · FY2015 · CA · contact PI

Development of Novel Therapeutic Strategies in Human Leukemias$2,307,647

P01 · FY2014 · CA · contact PI

Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,635,392

R24 · FY2014 · DK

Determination of the mechanism of lenalidomide activity in acute myeloid leukemia$327,796

P01 · FY2014 · CA · contact PI

Administrative Core$54,496

P01 · FY2014 · CA · contact PI

Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes$1,692,348

R24 · FY2013 · DK

Functional Genomic Dissection of Refractory Anemia$390,988

R01 · FY2013 · HL · contact PI

Molecular Genetic Investigation of Pediatric Myelodysplastic Syndrome$539,247

R24 · FY2012 · DK

Functional Genomic Dissection of Refractory Anemia$410,702

R01 · FY2012 · HL · contact PI

Functional Genomic Dissection of Refractory Anemia$414,588

R01 · FY2011 · HL · contact PI

NOVEL TREATMENT STRATEGIES FOR SICKLE CELL DISEASE$53,995

P51 · FY2011 · RR · contact PI

NOVEL TREATMENT STRATEGIES FOR SICKLE CELL DISEASE$53,995

P51 · FY2011 · RR · contact PI

Identification of functional tumor-stromal interactions in the bone marrow$499,998

RC1 · FY2010 · CA · contact PI

Functional Genomic Dissection of Refractory Anemia$413,800

R01 · FY2010 · HL · contact PI

NOVEL TREATMENT STRATEGIES FOR SICKLE CELL DISEASE$65,759

P51 · FY2010 · RR · contact PI

Identification of functional tumor-stromal interactions in the bone marrow$499,872

RC1 · FY2009 · CA · contact PI

Functional Dissection of Erythroid Differentiation$136,350

K08 · FY2009 · HL · contact PI

Functional Genomic Dissection of Refractory Anemia$430,154

R01 · FY2008 · HL · contact PI

Functional Dissection of Erythroid Differentiation$136,350

K08 · FY2008 · HL · contact PI

Functional Dissection of Erythroid Differentiation$131,490

K08 · FY2007 · HL · contact PI

High throughput screen for regulators of globin gene ex*$161,077

R01 · FY2006 · HG · contact PI

Functional Dissection of Erythroid Differentiation$131,490

K08 · FY2006 · HL · contact PI

Functional Dissection of Erythroid Differentiation$131,490

K08 · FY2005 · HL

High throughput screen for regulators of globin$125,891

R01 · FY2005 · HG